Roland Schrmann - Bachem Holding Chief Officer
BANB Stock | CHF 67.40 1.65 2.39% |
Insider
Roland Schrmann is Chief Officer of Bachem Holding AG
Age | 59 |
Phone | 41 58 595 2021 |
Web | https://www.bachem.com |
Bachem Holding Management Efficiency
The company has return on total asset (ROA) of 0.073 % which means that it generated a profit of $0.073 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1228 %, meaning that it generated $0.1228 on every $100 dollars invested by stockholders. Bachem Holding's management efficiency ratios could be used to measure how well Bachem Holding manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Adesh Kaul | Basilea Pharmaceutica AG | 49 | |
Peer Schroder | Basilea Pharmaceutica AG | N/A | |
Roberto Galli | Newron Pharmaceuticals SpA | N/A | |
Ngo Nhan | COSMO Pharmaceuticals SA | 44 | |
Alessandro LLM | COSMO Pharmaceuticals SA | 60 | |
Gerrit Hauck | Basilea Pharmaceutica AG | 59 | |
Gerhard Lobmaier | Evolva Holding SA | 54 | |
Niall Donnelly | COSMO Pharmaceuticals SA | 51 | |
Carsten Daweritz | Evolva Holding SA | 50 | |
Dario Eklund | Santhera Pharmaceuticals Holdin | 55 | |
Marc Schrader | Santhera Pharmaceuticals Holdin | N/A | |
Neville MD | Santhera Pharmaceuticals Holdin | N/A | |
Laurenz Kellenberger | Basilea Pharmaceutica AG | 56 | |
Oliver Strub | Santhera Pharmaceuticals Holdin | 60 | |
Fabienne Gschwind | Evolva Holding SA | 50 | |
Philipp Frech | Evolva Holding SA | N/A | |
Luigi Longo | COSMO Pharmaceuticals SA | 44 | |
Biagio Vigano | COSMO Pharmaceuticals SA | 49 | |
FCMA CGMA | Santhera Pharmaceuticals Holdin | 60 | |
Anne Vos | Evolva Holding SA | 59 | |
Davide Malavasi | COSMO Pharmaceuticals SA | 50 |
Management Performance
Return On Equity | 0.12 | |||
Return On Asset | 0.073 |
Bachem Holding AG Leadership Team
Elected by the shareholders, the Bachem Holding's board of directors comprises two types of representatives: Bachem Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bachem. The board's role is to monitor Bachem Holding's management team and ensure that shareholders' interests are well served. Bachem Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bachem Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Fruh, Sec | ||
Michael Suter, VP Accounting | ||
Roland Schrmann, Chief Officer | ||
Christian Sthelin, Director HR | ||
Gunther Loidl, Chief Officer | ||
JeanMarc Fellay, VP HR | ||
Thomas Meier, Chief Officer | ||
Michael Staroverov, Group Officer | ||
Alain Schaffter, Chief Officer | ||
Torsten Whr, Chief Officer |
Bachem Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bachem Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.12 | |||
Return On Asset | 0.073 | |||
Profit Margin | 0.20 % | |||
Operating Margin | 0.24 % | |||
Current Valuation | 5.89 B | |||
Shares Outstanding | 38.72 M | |||
Shares Owned By Insiders | 5.78 % | |||
Shares Owned By Institutions | 75.15 % | |||
Price To Earning | 137.53 X | |||
Price To Book | 5.69 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bachem Stock Analysis
When running Bachem Holding's price analysis, check to measure Bachem Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bachem Holding is operating at the current time. Most of Bachem Holding's value examination focuses on studying past and present price action to predict the probability of Bachem Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bachem Holding's price. Additionally, you may evaluate how the addition of Bachem Holding to your portfolios can decrease your overall portfolio volatility.